Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3655272013 | Powder for conventional release solution for infusion (dose form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3655273015 | Powder for conventional release solution for infusion | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3655274014 | Powder for solution for infusion | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial | Has manufactured dose form | True | Powder for conventional release solution for infusion (dose form) | Inferred relationship | Some | |
| Coagulation factor IX 500 unit powder for solution for infusion vial | Has manufactured dose form | True | Powder for conventional release solution for infusion (dose form) | Inferred relationship | Some | |
| Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | Has manufactured dose form | True | Powder for conventional release solution for infusion (dose form) | Inferred relationship | Some |
Start Page 2 of 2
This concept is not in any reference sets
FHIR